相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis
Guo-Qing Chen et al.
CELL DEATH AND DIFFERENTIATION (2020)
An Artemisinin-Derivative-(NHC)Gold(I) Hybrid with Enhanced Cytotoxicity through Inhibition of NRF2 Transcriptional Activity
Chen Zhang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Synthesis of Tamoxifen-Artemisinin and Estrogen-Artemisinin Hybrids Highly Potent Against Breast and Prostate Cancer
Tony Froehlich et al.
CHEMMEDCHEM (2020)
pH-Responsive Artesunate Polymer Prodrugs with Enhanced Ablation Effect on Rodent Xenograft Colon Cancer
Dan-Li Hao et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Dihydroartemisinin Inhibits the Proliferation of Leukemia Cells K562 by Suppressing PKM2 and GLUT1 Mediated Aerobic Glycolysis
Peng Gao et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
Autophagy-dependent cell cycle arrest in esophageal cancer cells exposed to dihydroartemisinin
Qiang Ma et al.
CHINESE MEDICINE (2020)
Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma
Ying Chen et al.
FRONTIERS IN ONCOLOGY (2020)
RalB degradation by dihydroartemisinin induces autophagy and IFI16/caspase-1 inflammasome depression in the human laryngeal squamous cell carcinoma
Xinli Shi et al.
CHINESE MEDICINE (2020)
Artesunate induces apoptosis and inhibits the proliferation, stemness, and tumorigenesis of leukemia
Shengmei Chen et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Dihydroartemisinin inhibits the migration of esophageal cancer cells by inducing autophagy
Xiao Chen et al.
ONCOLOGY LETTERS (2020)
Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33/2)
Cornelia von Hagens et al.
PHYTOMEDICINE (2019)
Dihydroartemisinin-Bile Acid Hybridization as an Effective Approach to Enhance Dihydroartemisinin Anticancer Activity
Elena Marchesi et al.
CHEMMEDCHEM (2019)
Biological Activities of Artemisinin Derivatives Beyond Malaria
Xiaoyan Liu et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin
Jing Du et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Effects of magnetic dihydroartemisinin nano-liposome in inhibiting the proliferation of head and neck squamous cell carcinomas
Li Hui et al.
PHYTOMEDICINE (2019)
Dihydroartemisinin, an antimalarial drug, induces absent in melanoma 2 inflammasome activation and autophagy in human hepatocellular carcinoma HepG2215 cells
Xinli Shi et al.
PHYTOTHERAPY RESEARCH (2019)
Artemisinin-indole and artemisinin-imidazole hybrids: Synthesis, cytotoxic evaluation and reversal effects on multidrug resistance in MCF-7/ADR cells
Yanping Hu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Mitochondria-targeted triphenylphosphonium conjugated glycyrrhetinic acid derivatives as potent anticancer drugs
Le Jin et al.
BIOORGANIC CHEMISTRY (2019)
Artesunate promotes Th1 differentiation from CD4+ T cells to enhance cell apoptosis in ovarian cancer via miR-142
Xiao Chen et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2019)
Cell death: a review of the major forms of apoptosis, necrosis and autophagy
Mark S. D'Arcy
CELL BIOLOGY INTERNATIONAL (2019)
Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo
Yu Cao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
A Temporizing Solution to Artemisinin Resistance
Jigang Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Development of R8 modified epirubicin-dihydroartemisinin liposomes for treatment of non-small-cell lung cancer
Jing-Jing Liu et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Artemisinin-(Iso)quinoline Hybrids by C-H Activation and Click Chemistry: Combating Multidrug-Resistant Malaria
Aysun Capci et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Dihydroartemisinin represses esophageal cancer glycolysis by down-regulating pyruvate kinase M2
Shumin Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Role of GRP78 inhibiting artesunate-induced ferroptosis in KRAS mutant pancreatic cancer cells
Kang Wang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Artemether Attenuates the Progression of Non-small Cell Lung-Cancer by Inducing Apoptosis, Cell Cycle Arrest and Promoting Cellular Senescence
Jian Chen et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2019)
Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells
Yibing Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Dihydroartemisinin suppresses glycolysis of LNCaP cells by inhibiting PI3K/AKT pathway and downregulating HIF-1α expression
Wenhe Zhu et al.
LIFE SCIENCES (2019)
Dihydroartemisinin and doxorubicin co-loaded Soluplus®-TPGS mixed micelles: formulation characterization, cellular uptake, and pharmacodynamic studies
Yutong Wang et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2019)
Artesunate activates the ATF4-CHOP-CHAC1 pathway and affects ferroptosis in Burkitt's Lymphoma
Ning Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
The anti-malarial drug artesunate causes cell cycle arrest and apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3 breast cancer cells
Anna L. Greenshields et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2019)
Biotin-functionalized copolymeric PEG-PCL micelles for in vivo tumour-targeted delivery of artemisinin
Flamed Nosrati et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Dihydroartemisinin Sensitizes Mutant p53 (R248Q)-Expressing Hepatocellular Carcinoma Cells to Doxorubicin by Inhibiting P-gp Expression
Yue Yang et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Synthesis of Thymoquinone-Artemisinin Hybrids: New Potent Antileukemia, Antiviral, and Antimalarial Agents
Tony Froehlich et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Induction of autophagy and autophagy-dependent apoptosis in diffuse large B-cell lymphoma by a new antimalarial artemisinin derivative, SM1044
Chunyan Cheng et al.
CANCER MEDICINE (2018)
Artemisinin and AlEgen Conjugate for Mitochondria-Targeted and Image-Guided Chemo- and Photodynamic Cancer Cell Ablation
Guangxue Feng et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Novel Hybrid Compound 4-[(E)-2-phenylethenesulfonamido]-N-hydroxybutananide with Antimetastatic and Cytotoxic Action: Synthesis and Anticancer Screening
Yurii L. Zborovskii et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2018)
Dihydroartemisinin potentiates antitumor activity of 5-fluorouracil against a resistant colorectal cancer cell line
Zhihan Yao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Dihydroartemisinin suppresses STAT3 signaling and Mcl-1 and Survivin expression to potentiate ABT-263-induced apoptosis in Non-small Cell Lung Cancer cells harboring EGFR or RAS mutation
Xiaohui Yan et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Autophagy in health and disease: A comprehensive review
Sarbari Saha et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies
John F. Deeken et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents
Haonan Yu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Artesunate induces apoptosis and autophagy in HCT116 colon cancer cells, and autophagy inhibition enhances the artesunate-induced apoptosis
Feng Jiang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
Artesunate shows potent anti-tumor activity in B-cell lymphoma
Thea Kristin Vatsveen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Dihydroartemisinin sensitizes Lewis lung carcinoma cells to carboplatin therapy via p38 mitogen-activated protein kinase activation
Bicheng Zhang et al.
ONCOLOGY LETTERS (2018)
The Role of Ferroptosis in Cancer Development and Treatment Response
Bin Lu et al.
FRONTIERS IN PHARMACOLOGY (2018)
Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives
Gantumur Battogtokh et al.
ACTA PHARMACEUTICA SINICA B (2018)
Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
Amila Suraweera et al.
FRONTIERS IN ONCOLOGY (2018)
Artemisinin-Daumone Hybrid Inhibits Cancer Cell-Mediated Osteolysis by Targeting Cancer Cells and Osteoclasts
Gwang Taek Ma et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Targeted Nanostructured Lipid Carrier for Brain Delivery of Artemisinin: Design, Preparation, Characterization, Optimization and Cell Toxicity
Jaber Emami et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2018)
Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway
Suyanee Thongchot et al.
MOLECULAR CARCINOGENESIS (2018)
Novel dihydroartemisinin derivative DHA-37 induces autophagic cell death through upregulation of HMGB1 in A549 cells
Xiufeng Liu et al.
CELL DEATH & DISEASE (2018)
Synergistic Anticancer Potential of Artemisinin When Loaded with 8-Hydroxyquinoline-Surface Complexed-Zinc Ferrite Magnetofluorescent Nanoparticles and Albumin Composite
Uday Narayan Pan et al.
ACS APPLIED BIO MATERIALS (2018)
Iron Oxide Nanocarrier-Mediated Combination Therapy of Cisplatin and Artemisinin for Combating Drug Resistance through Highly Increased Toxic Reactive Oxygen Species Generation
Zhiguo Gao et al.
ACS APPLIED BIO MATERIALS (2018)
Antitumor Research on Artemisinin and Its Bioactive Derivatives
Yunqin Zhang et al.
NATURAL PRODUCTS AND BIOPROSPECTING (2018)
Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin
S. Elf et al.
ONCOGENE (2017)
Anti-angiogenic properties of artemisinin derivatives
Tianshu Wei et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Mitochondria-Targeted Lupane Triterpenoid Derivatives and Their Selective Apoptosis-Inducing Anticancer Mechanisms
Yaqing Ye et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action
Yin Kwan Wong et al.
MEDICINAL RESEARCH REVIEWS (2017)
Dihydroartemisinin and gefitinib synergistically inhibit NSCLC cell growth and promote apoptosis via the Akt/mTOR/STAT3 pathway
Hong Jin et al.
MOLECULAR MEDICINE REPORTS (2017)
Cancer combination therapy of the sesquiterpenoid artesunate and the selective EGFR-tyrosine kinase inhibitor erlotinib
Thomas Efferth
PHYTOMEDICINE (2017)
From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy
Thomas Efferth
SEMINARS IN CANCER BIOLOGY (2017)
Dihydroartemisinin Exerts Anti-Tumor Activity by Inducing Mitochondrion and Endoplasmic Reticulum Apoptosis and Autophagic Cell Death in Human Glioblastoma Cells
Chengbin Qu et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Dihydroartemisinin induces autophagy-dependent death in human tongue squamous cell carcinoma cells through DNA double-strand break-mediated oxidative stress
Xinli Shi et al.
ONCOTARGET (2017)
Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells
Yin Li et al.
CLINICAL EPIGENETICS (2017)
Targeting NF-kappa B Signaling by Artesunate Restores Sensitivity of Castrate-Resistant Prostate Cancer Cells to Antiandrogens
Jessica J. Nunes et al.
NEOPLASIA (2017)
Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis
Jong-Lyel Roh et al.
REDOX BIOLOGY (2017)
A mitochondria-targeting artemisinin derivative with sharply increased antitumor but depressed anti-yeast and anti-malaria activities
Chen Sun et al.
SCIENTIFIC REPORTS (2017)
m Modulation of Navitoclax Sensitivity by Dihydroartemisinin-Mediated MCL-1 Repression in BCR-ABL+ B-Lineage Acute Lymphoblastic Leukemia
Amit Budhraja et al.
CLINICAL CANCER RESEARCH (2017)
Dihydroartemisinin and Curcumin Synergistically Induce Apoptosis in SKOV3 Cells Via Upregulation of MiR-124 Targeting Midkine
Jiaojiao Zhao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Dihydroartemisinin Sensitizes Human Lung Adenocarcinoma A549 Cells to Arsenic Trioxide via Apoptosis
Hongyu Chen et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2017)
Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications
Jacek Zielonka et al.
CHEMICAL REVIEWS (2017)
Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)
Cornelia von Hagens et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Synthesis and cytotoxic activity of new artemisinin hybrid molecules against human leukemia cells
Antonios S. Letis et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Synthesis of Novel Hybrids of Thymoquinone and Artemisinin with High Activity and Selectivity Against Colon Cancer
Tony Froehlich et al.
CHEMMEDCHEM (2017)
Mechanism-Guided Design and Synthesis of a Mitochondria-Targeting Artemisinin Analogue with Enhanced Anticancer Activity
Chong-Jing Zhang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Artemisinin-A Gift from Traditional Chinese Medicine to the World (Nobel Lecture)
Youyou Tu
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
High-throughput screening identifies artesunate as selective inhibitor of cancer sternness: Involvement of mitochondrial metabolism
Amit Subedi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Magnetically guided delivery of DHA and Fe ions for enhanced cancer therapy based on pH-responsive degradation of DHA-loaded Fe3O4@C@MIL-100(Fe) nanoparticles
Dongdong Wang et al.
BIOMATERIALS (2016)
Controllable synthesis of dual-MOFs nanostructures for pH-responsive artemisinin delivery, magnetic resonance and optical dual-model imaging-guided chemo/photothermal combinational cancer therapy
Dongdong Wang et al.
BIOMATERIALS (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study
Miriam Koenig et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Evaluation of artemisinins for the treatment of acute myeloid leukemia
Christina D. Drenberg et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells
Renyu Lin et al.
CANCER LETTERS (2016)
Ferroptosis: process and function
Y. Xie et al.
CELL DEATH AND DIFFERENTIATION (2016)
Enhanced Efficacy of Artemisinin Loaded in Transferrin-Conjugated Liposomes versus Stealth Liposomes against HCT-8 Colon Cancer Cells
Isabella Leto et al.
CHEMMEDCHEM (2016)
Synthesis and in vitro antitumor evaluation of dihydroartemisinin-cinnamic acid ester derivatives
Cang-Cang Xu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Artemisinin-Derived Dimers: Potent Antimalarial and Anticancer Agents
Tony Frohlich et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Artemisinin inhibits gallbladder cancer cell lines through triggering cell cycle arrest and apoptosis
Jianguang Jia et al.
MOLECULAR MEDICINE REPORTS (2016)
Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/β-catenin signaling
Yunli Tong et al.
ONCOTARGET (2016)
Artesunate enhances the therapeutic response of glioma cells to temozolomide by inhibition of homologous recombination and senescence
Nancy Berte et al.
ONCOTARGET (2016)
Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer
Xiaoguang Li et al.
EBIOMEDICINE (2016)
Development and Evaluation of Artesunate-Loaded Chitosan-Coated Lipid Nanocapsule as a Potential Drug Delivery System Against Breast Cancer
Tuan Hiep Tran et al.
AAPS PHARMSCITECH (2015)
p8 attenuates the apoptosis induced by dihydroartemisinin in cancer cells through promoting autophagy
Sang-Sang Chen et al.
CANCER BIOLOGY & THERAPY (2015)
Artesunate sensitizes ovarian cancer cells to cisplatin by downregulating RAD51
Bingliang Wang et al.
CANCER BIOLOGY & THERAPY (2015)
Fluorescent Coumarin-Artemisinin Conjugates as Mitochondria-Targeting Theranostic Probes for Enhanced Anticancer Activities
Xu Zhang et al.
CHEMISTRY-A EUROPEAN JOURNAL (2015)
New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids
Christoph Reiter et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Artesunate down-regulates immunosuppression from colorectal cancer Colon26 and RKO cells in vitro by decreasing transforming growth factor β1 and interleukin-10
Cheng Cui et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
pH-Responsive Artemisinin Dimer in Lipid Nanoparticles Are Effective Against Human Breast Cancer in a Xenograft Model
Yitong J. Zhang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Mn(II) mediated degradation of artemisinin based on Fe3O4@MnSiO3-FA nanospheres for cancer therapy in vivo
Jian Chen et al.
NANOSCALE (2015)
Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells
Edna Ooko et al.
PHYTOMEDICINE (2015)
Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy
Ze-Shun Zhang et al.
ONCOLOGY LETTERS (2015)
Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis
Da Eun Jeong et al.
ONCOTARGET (2015)
Dihydroartemisinin Inhibits Glucose Uptake and Cooperates with Glycolysis Inhibitor to Induce Apoptosis in Non-Small Cell Lung Carcinoma Cells
Yan-jun Mi et al.
PLOS ONE (2015)
An Overview of Autophagy: Morphology, Mechanism, and Regulation
Katherine R. Parzych et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Synergistic induction of apoptosis in A549 cells by dihydroartemisinin and gemcitabine
Chubiao Zhao et al.
APOPTOSIS (2014)
Dihydroartemisinin potentiates the anticancer effect of cisplatin via mTOR inhibition in cisplatin-resistant ovarian cancer cells: involvement of apoptosis and autophagy
Xue Feng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Multifunctional mesoporous nanoparticles as pH-responsive Fe2+ reservoirs and artemisinin vehicles for synergistic inhibition of tumor growth
Jian Chen et al.
BIOMATERIALS (2014)
Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma
Xiu-Ying Li et al.
BIOMATERIALS (2014)
Artesunate exerts an anti-immunosuppressive effect on cervical cancer by inhibiting PGE2 production and Foxp3 expression
Li-xin Zhang et al.
CELL BIOLOGY INTERNATIONAL (2014)
Nanocapsules based on mPEGylated artesunate prodrug and its cytotoxicity
Haijing Meng et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2014)
Artemisinin and Curcumin Inhibit Drosophila Brain Tumor, Prolong Life Span, and Restore Locomotor Activity
Sourajit Soumyaranjan Das et al.
IUBMB LIFE (2014)
The activation of c-Jun NH2-terminal kinase is required for dihydroartemisinin-induced autophagy in pancreatic cancer cells
Guang Jia et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Artemisinins: Pharmacological actions beyond anti-malarial
Wanxing Eugene Ho et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Preparation, characterization and in vitro efficacy of magnetic nanoliposomes containing the artemisinin and transferrin
Amir Gharib et al.
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Dihydroartemisinin exhibits anti-glioma stem cell activity through inhibiting p-AKT and activating caspase-3
Liu Cao et al.
PHARMAZIE (2014)
Artesunate inhibits the growth of gastric cancer cells through the mechanism of promoting oncosis both in vitro and in vivo
Xiang Zhou et al.
ANTI-CANCER DRUGS (2013)
Dihydroartemisinine Enhances Dictamnine-induced Apoptosis via a Caspase Dependent Pathway in Human Lung Adenocarcinoma A549 Cells
Fu-Fei An et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Synergism of Cytotoxicity Effects of Triptolide and Artesunate Combination Treatment in Pancreatic Cancer Cell Lines
Yao Liu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Initiation of apoptosis, cell cycle arrest and autophagy of esophageal cancer cells by dihydroartemisinin
Xiao-Xue Du et al.
BIOMEDICINE & PHARMACOTHERAPY (2013)
DHA regulates angiogenesis and improves the efficiency of CDDP for the treatment of lung carcinoma
Jia-Li Zhang et al.
MICROVASCULAR RESEARCH (2013)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Antitumor Activity of Artemisinin and Its Derivatives: From a Well-Known Antimalarial Agent to a Potential Anticancer Drug
Maria P. Crespo-Ortiz et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Artemisinin inhibits in vitro and in vivo invasion and metastasis of human hepatocellular carcinoma cells
Tan Weifeng et al.
PHYTOMEDICINE (2011)
Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro
Hui-Jun Zhou et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo
Ji-Hui Du et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Dihydroartemisinin inactivates NF-κB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo
Shuang-Jia Wang et al.
CANCER LETTERS (2010)
Next-Generation Antimalarial Drugs: Hybrid Molecules as a New Strategy in Drug Design
Francis W. Muregi et al.
DRUG DEVELOPMENT RESEARCH (2010)
First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases
Suhail Ahmed Kabeer Rasheed et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Discovery, mechanisms of action and combination therapy of artemisinin
Liwang Cui et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2009)
Anticancer activities of artemisinin and its bioactive derivatives
Gary L. Firestone et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
Artemisinin dimer anticancer activity correlates with heme-catalyzed reactive oxygen species generation and endoplasmic reticulum stress induction
Luke H. Stockwin et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy
Tao Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Hybrid molecules with a dual mode of action: Dream or reality?
Bernard Meunier
ACCOUNTS OF CHEMICAL RESEARCH (2008)
Cancer cell metabolism: Warburg and beyond
Peggy P. Hsu et al.
CELL (2008)
Cell death by necrosis: towards a molecular definition
Pierre Golstein et al.
TRENDS IN BIOCHEMICAL SCIENCES (2007)
Risk assessment and therapeutic indices of artesunate and artelinate in Plasmodium berghei - Infected and uninfected rats
LH Xie et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2005)
Toxicokinetics and hydrolysis of artelinate and artesunate in malaria-infected rats
QG Li et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2005)
Combination-treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774
T Efferth et al.
BIOCHEMICAL PHARMACOLOGY (2004)
An over four millennium story behind qinghaosu (Artemisinin) - A fantastic antimalarial drug from a traditional Chinese herb
Y Li et al.
CURRENT MEDICINAL CHEMISTRY (2003)
Morphological and biochemical aspects of apoptosis, oncosis and necrosis
S Van Cruchten et al.
ANATOMIA HISTOLOGIA EMBRYOLOGIA (2002)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Behavioral and neural toxicity of the artemisinin antimalarial, arteether, but not artesunate and artelinate, in rats
RE Genovese et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2000)
分享论文
